Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Since relative or absolute insulin deficiency and insulin insensitivity are involved in the aetiology of non-insulin-dependent diabetes mellitus (NIDDM), we examined whether patients with NIDDM exhibit genetic variability in the coding region of insulin receptor substrate-1 (IRS-1), a candidate gene that is ubiquitous in insulin-sensitive and insulin-like growth factor 1 (IGF1) sensitive tissues, including those that determine glucose production and clearance and those with regulatory effects on pancreatic beta-cell function. 8104271 1993
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE In conclusion, variability in the coding regions of IGF-I and the IGF-IR does not associate with reduced birth weight, insulin sensitivity index, or type 2 diabetes in the Danish population. 10770205 2000
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE A common genetic polymorphism in the IGF1 gene could influence size at birth, postnatal growth and type 2 diabetes risk, but results of studies have been inconsistent. 14671410 2003
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We studied, prospectively, the relationship between an IGF-I gene polymorphism, retinal vessel diameters, and incident diabetic retinopathy in subjects with impaired glucose tolerance (IGT) or type 2 diabetes. 16873705 2006
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease LHGDN We sought further evidence for the involvement of this variant in type 2 diabetes using a case-control study and IGF-I and diabetes-related traits in a population cohort of 640 U.K. individuals aged 25 years. 12086966 2002
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We analyzed nine single-nucleotide polymorphisms (SNPs), including rs340874 (PROX1), rs4607517 (GCK), rs2191349 (DGKB-TMEM195), rs7034200 (GLIS3), rs10885122 (ADRA2A), rs174550 (FADS1), rs11605924 (CRY2), rs10830963 (MTNR1B) and rs35767 (IGF1). rs340874 (PROX1) and rs174550 (FADS1) were significantly associated with T2D (P=0.0078, OR: 1.12; and P=0.0071, OR: 1.12, respectively). 22992776 2012
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We aimed to show that a polymorphism in the gene for insulin-like growth factor-I, which has proved to raise risk of type 2 diabetes and myocardial infarction, is associated with low birthweight. 11937187 2002
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We examined the role of a genetic polymorphism in the promoter region of the IGF-I gene in relation to circulating IGF-I levels and growth measured as body height, and we studied the relationship of this polymorphism with type 2 diabetes and myocardial infarction. 11246885 2001
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE Evidence is accumulating that the promoter region of the insulin-like growth factor I (IGF-I) gene polymorphism and low levels of IGF-I are associated with type 2 diabetes, cardiovascular disease and birth weight; however, the number of wild-type alleles is different in each country. 17377412 2007
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE This study aimed to assess the association of serum IGF-1 and IGF binding protein (IGFBP)-3 levels with cognition status and to determine whether IGF-1 rs972936 polymorphism is associated with T2DM with mild cognitive impairment (MCI). 26402757 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE As compared to IGF1 19-CA wild-type carriers without T2DM, carrying two IGF1 19-CA variant repeat alleles were associated with a significantly decreased CRC risk in those without T2DM (HR = 0.76, 95% CI: 0.63-0.91). 31018241 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We sought further evidence for the involvement of this variant in type 2 diabetes using a case-control study and IGF-I and diabetes-related traits in a population cohort of 640 U.K. individuals aged 25 years. 12086966 2002
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE We investigated whether this IGF-I promoter polymorphism is associated with survival of type 2 diabetes in a Caucasian population aged 55 years and older. 17062892 2006
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE The common polymorphisms of the IGF-1R, IRS-1 and IRS-2 genes may modify the weight change response to a lifestyle intervention but not the conversion from IGT to Type 2 diabetes, whereas IGF-1R may also regulate the risk of developing Type 2 diabetes. 15127203 2004
Diabetes Mellitus, Non-Insulin-Dependent
0.300 GeneticVariation disease BEFREE There were significant differences between the T2DM and control groups in frequencies of the risk allelic distributions of rs7754840 (CDKAL1) (p=0.014), rs864745 (JAZF1) (p=0.032), and rs35767 (IGF1) (p=0.044). 25785549 2015
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE We aimed to examine the usefulness of combined evaluation by BMD and serum insulin-like growth factor-I (IGF-I) to assess the risk of vertebral fracture (VF) in T2DM. 30030585 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Background Previous genome-wide association studies (GWAS) identified IGF1, IRS1, GCKR, PPARG, GCK1 and KCTD1 as candidate genes for insulin resistance and type 2 diabetes (T2D). 30864372 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE (1) In contrast, targeting the human insulin-like growth factor 1 (IGF-1) receptor with neutralizing antibodies significantly suppressed insulin-induced outgrowth of EPCs from both healthy controls and patients with type 2 diabetes. 18309377 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE IGF-1R may play an important role in carcinogenesis and tumor growth in PTC patients with T2DM. 28328831 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE To study the role of PAPP-A and the IGF system in diabetic polyneuropathy (DPN), we measured immunoreactive (total) concentrations of IGF-I and IGF-II, bioactive IGF by cell-based bioassay, PAPP-A, as well as intact and PAPP-A-cleaved IGFBP-4 in cerebrospinal fluid (CSF) and serum from patients with type 2 diabetes (T2D) with and without DPN. 31670029 2020
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE After 8 weeks, the type 2 diabetes nephropathy model was successfully set up the different drugs were administrated to mice with diabetes (insulin 1-2 U/day, benazepril 10 mg/kg per day intragastrically, IGF-1R inhibitor 30 mg/kg per day intragastrically). 30254418 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE BMI = body mass index; GH = growth hormone; IGF-1 = insulin-like growth factor 1; MRI = magnetic resonance imaging; PSA = prostate-specific antigen; T2DM = type 2 diabetes mellitus; VA-NWIHCS = VA-Nebraska Western Iowa Health Care System. 30289304 2018
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE Insulin-like growth factor I, binding proteins -1 and -3, risk of type 2 diabetes and macronutrient intakes in men. 30898176 2019
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease BEFREE MicroRNA-29 regulates myocardial microvascular endothelial cells proliferation and migration in association with IGF1 in type 2 diabetes. 28315330 2017
Diabetes Mellitus, Non-Insulin-Dependent
0.300 Biomarker disease RGD MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. 18986336 2009